Prosecution Insights
Last updated: April 19, 2026

Examiner: DONOHUE, SEAN R

Tech Center 1600 • Art Units: 1618

This examiner grants 42% of resolved cases

Performance Statistics

41.6%
Allow Rate
-18.4% vs TC avg
775
Total Applications
+21.9%
Interview Lift
1274
Avg Prosecution Days
Based on 723 resolved cases, 2023–2026

Rejection Statute Breakdown

1.3%
§101 Eligibility
10.7%
§102 Novelty
50.4%
§103 Obviousness
20.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18027311 NON-INVASIVE FUNCTIONAL COMPANION ASSAYS FOR ONCOGENE TARGETED THERAPY FOR BRAIN CANCER Non-Final OA The Regents of the University of California
17997295 METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITS Final Rejection Novartis AG
17997299 METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITS Final Rejection Novartis AG
17432698 RADIOPAQUE MEDICAL COMPONENTS AND DEVICES Non-Final OA DSM IP Assets B.V.
19266396 ZWITTERIONIC METAL CHELATORS Final Rejection Curadel Surgical Innovations, Inc.
19208200 [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF Final Rejection Curium US LLC
17550542 BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY Final Rejection The Johns Hopkins University
17264222 COMPETITIVE PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) BINDING AGENTS FOR REDUCTION OF NON-TARGET ORGAN UPTAKE OF RADIOLABELED PSMA INHIBITORS FOR PSMA POSITIVE TUMOR IMAGING AND RADIOPHARMACEUTICAL THERAPY Non-Final OA The Johns Hopkins University
17253336 POSITRON EMISSION TOMOGRAPHY (PET) RADIOTRACERS FOR IMAGING MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R) IN NEUROINFLAMMATION Non-Final OA The Johns Hopkins University
18099924 RADIOLIGANDS FOR MYELIN Non-Final OA CASE WESTERN RESERVE UNIVERSITY
17919848 Fluorinated Derivatives of Gabapentin and Methods of Use Thereof Final Rejection The General Hospital Corporation
18542674 HEAT RESISTANT GENERATOR COLUMNS FOR ELUTION SYSTEMS Final Rejection Jubilant Draximage Inc.
17705781 Multi-Enzyme Nanoparticle-Assisted Stable Isotope Incorporation Into Small Molecules by Channeling Non-Final OA The Government of the United States of America, as represented by the Secretary of the Navy
18247427 METHODS AND COMPOSITIONS FOR SYNERGISTIC UPTAKE AND RETENTION OF SMALL MOLECULE LIGANDS Non-Final OA CORNELL UNIVERSITY
18029596 METHODS AND COMPOSITIONS FOR INCREASING UPTAKE, INTERNALIZATION, AND/OR RETENTION OF SMALL MOLECULE LIGANDS Non-Final OA CORNELL UNIVERSITY
18666047 SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME Non-Final OA BLUE HILL TECHNOLOGIES LLC
18632964 Imaging Agents Non-Final OA UCB Biopharma SRL
18628420 COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE Final Rejection Sciencons AS
17725271 BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER Final Rejection The Governors of the University of Alberta
18603721 COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES Non-Final OA Wake Forest University Health Sciences
17922583 COPPER-CONTAINING THERAGNOSTIC COMPOSITIONS AND METHODS OF USE Final Rejection The University of Melbourne
18384509 MOF FOR RADIOTHERAPY Final Rejection Node Pharma AS
18343960 METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES Non-Final OA UNIVERSITY OF OTTAWA
17631600 RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS Non-Final OA THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic
18123236 Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy Final Rejection Georgia State University Research Foundation, Inc.
18246944 MACROCYCLIC HOST MOLECULE-BASED CORE-SHELL NANOPARTICLES AND METHOD FOR SYNTHESIZING SAME Non-Final OA BIONANO HEALTH GUARD RESEARCH CENTER
18260272 DUAL MODE RADIOTRACER AND -THERAPEUTICS Non-Final OA TECHNISCHE UNIVERSITÄT MÜNCHEN - KLINIKUM RECHTS DER ISAR
18301896 METHOD OF SYNTHESIZING 18F RADIOLABELED BIOMOLECULAR AGENTS Non-Final OA Theracea Pharma, LC
17802190 THIOPURINE-BASED COMPOUND, COMPOSITION, METHOD OF PREPARATION AND APPLICATIONS Non-Final OA SEECURE TAIWAN CO., LTD.
17792571 RADIONUCLIDE-LHRH CONJUGATES FOR DIAGNOSIS OF REPRODUCTIVE CANCERS Non-Final OA EASTERN KENTUCKY UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month